Study Description

The Cholesterol and Pharmacogenetics Study was a 6-week open label, non-randomized study of 40mg/day simvastatin treatment in 944 African... Show More

Study Accession Alternative Stable ID type
phs000481.v1.p1 dbGaP Clinical Trial

Who controls access to this study

National Heart, Lung, and Blood Institute DAC
Access information:

Publications

16516587
20339536

Data provider(s)

  • Title Name Institute
    Principal Investigator Ronald M. Krauss, MD Children's Hospital Oakland Research Institute, Oakland, CA
    Co-investigator Stephen B. Hulley, MD, MPH University of California, San Francisco CA
    Co-investigator Joel Simon, MD, MPH University of California, San Francisco CA
    Co-investigator David Waters, MD University of California, San Francisco CA
    Co-investigator Mohammed Saad, MD University of California, Los Angeles CA

Who archives the data?

The database of Genotypes and Phenotypes (dbGaP)